Lenisna-injectable collagen stimulator

LENISNAis ahybrid fillerthat combines boththe benefits of immediate filling effect with HA (hyaluronic acid)andlong-term stimulation of collagen production through PDLLA (Poly D,L-lactide).

Due to patented manufacturing technology, patents no. 10-1481441, no. 10-1725279, a preparation with unique properties has been created: long-lasting efficacy and an enhanced safety profile.

LENISNAis designed as a time-released filler material, with a concentration of 170 mg of polylactic acid PDLLA and 30 mg of non-cross-linked hyaluronic acid.

By adjusting the quantity of solution and particle size from 50 to 60 micrometers and combining them with non-cross-linked hyaluronic acid, a hybrid has been obtained that is suitable for application in subcutaneous or periosteal tissue.

It is intended for treatment of deep wrinkles, laxity, and significant tissue defects.

Due to the combination of polylactic acid PDLLA with hyaluronic acid HA, we obtain a visible effect immediately after treatment.

The filler is maintained until the production of new collagen and elastin by the polylactic acid begins to dominate.

The recommended number of treatments is 2 or 3, depending on skin deficiency, at intervals of 6-8 weeks.

After two years, a maintenance treatment is recommended.

The displayed price is for 1 vial and includes VAT.